Conditional Knockdown of Proteasomes Results in Cell-cycle Arrest and Enhanced Expression of Molecular Chaperones Hsp70 and Hsp40 in Chicken DT40 Cells*

Tomoko Tanahashi-HoriDagger , Nobuyuki Tanahashi§, Keiji TanakaDagger , and Tomoki ChibaDagger

From the Dagger  Department of Molecular Oncology, The Tokyo Metropolitan Institute of Medical Science, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8613 and the § EPM Project Groups, Osaka R&D Laboratories, Sumitomo Electric Industries Ltd., and New Energy and Industrial Technology Development Organization, Taya-cho 1, Sakae-ku, Yokohama 244-8588, Japan

Received for publication, February 6, 2003

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The 26 S proteasome is an evolutionarily conserved ATP-dependent protease complex that degrades poly-ubiquitinated proteins and plays essential roles in a critical part of cellular regulation. In vertebrates, the roles of the proteasome have been widely studied by use of specific inhibitors, but not genetically. Here, we generated a cell line Z-/-/-/Z-HA, in which the expression of the catalytic subunit of the proteasome, Z (beta 2) could be manipulated. This cell line expresses exogenous Z protein under the control of a tetracycline-repressible promoter in a Z-nullizygous genetic background. Treatment of these cells with doxycycline inhibited Z expression and, hence, the function of the proteasome. The latter resulted in accumulation of poly-ubiquitinated proteins and concomitant induction of molecular chaperones Hsp70 and Hsp40. These results suggest a synergistic role for the proteasome with these molecular chaperones to eliminate misfolded or damaged proteins in vivo. Furthermore, knockdown of the proteasome induced apoptotic cell death following cell-cycle arrest at G2/M phase. Our Z-/-/-/Z-HA cell line would be useful for evaluating proteolytic processes catalyzed by the proteasome in many biological events in vertebrate cells.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The 26 S proteasome with a molecular mass of ~2500 kDa consists of the central 20 S protease (catalytic core) and two outer 19 S regulatory particles (alias PA700), functioning as a protein-destroying machine responsible for energy-dependent proteolysis (1, 2). The 20 S proteasome is composed of two copies of 14 different subunits: 7 distinct alpha  and 7 distinct beta  type subunits. It is a barrel-like particle formed by the axial stacking of four rings made up of two outer alpha -rings and inner beta -rings, being associated in the order of alpha beta beta alpha . Three out of seven beta -type subunits of each inner ring have catalytically active threonine residues at their N termini, and these active sites reside in a chamber formed by the centers of the abutting beta -rings. The eukaryotic 20 S proteasome has at least three different catalytic activities against synthetic peptide substrates; i.e. a trypsin-like, chymotrypsin-like, and caspase-like (or peptidylglutamyl-hydrolyzing) activities, that contribute to the hydrolysis of multiple peptide bonds in a single polypeptide by a coordinated mechanism (1, 3, 4).

To date, yeast proteasomal mutants and membrane-permeable inhibitors have been used to determine in vivo functions of proteasomes, which have created diverse arrays of evidence on the biological importance of proteasomes such as the cell cycle, immune response, signaling cascades, and protein quality control in various eukaryotes (5, 6). Indeed, budding yeast mutants that lack some peptidase activities have contributed greatly to our understanding of the involvement of proteasomes in the degradation of many unstable key proteins (7), but their application to higher organisms has not been tested. Various substrate-related peptidyl compounds such as MG-132 and Z-L3VS have been devised as potent inhibitors of proteasomes (8, 9), but caution must be exercised in their use for interpreting proteasome functions, because they inhibit not only proteasomes but also other proteases. In contrast to these compounds, new microbial metabolites, such as lactacystin and eponemycin, were found to induce selective inhibition of proteasomes that do not affect other proteases examined so far (10, 11). However, although these metabolites bind to active threonine residues of proteasomes, the possibility that they inhibit other as-yet-unidentified threonine protease(s) cannot be ruled out completely. Therefore, genetic approaches capable of manipulating proteasomal activities are still required to determine the in vivo functions of proteasomes in higher organisms such as vertebrate cells.

For this purpose, we disrupted proteasome subunit Z (formally designated beta 2) gene (cpsmb7) in chicken B cell line DT40 then established Z-/-/-/Z-HA cells that express a tetracycline-repressible HA1-tagged Z protein (Z-HA). This construct could manipulate proteasome levels in vertebrate cells by repressing the Z-HA by doxycycline (Dox) treatment. Using these cells, we found that reduction of proteasomes caused not only G2/M arrest during cell-cycle progression but also induction of apoptosis. Moreover, our results surprisingly showed that reduced proteasomes functions induced the expression of major molecular chaperones Hsp70 and Hsp40, suggesting a potential link between proteasome-mediated proteolysis and stress response for protein homeostasis in the cell.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Plasmid Constructs-- Partial chicken Z cDNA was obtained from DT40 cells-derived mRNAs by reverse transcription-PCR method. The primers (5'-GACACGAGGGCGACCGAAGGGATG-3' and 5'-GCGGCTGCTCAGGAAGTATCCATG-3') were synthesized based on expressed sequence tag sequence (AJ397675). The full-length cDNA and genomic DNA were obtained by screening chicken muscle cDNA and genomic DNA libraries (Stratagene). The Z targeting vectors were designed by replacing the DNA segment that encompasses exon 1 to exon 3, with drug-resistant cassettes for blasticidin (Bsd), puromycin (Puro), and phleomycin (Bleo). A hemagglutinin (HA) tag was fused to the 3'-end of chicken Z cDNA coding regions by PCR amplifications. HA-tagged chicken Z cDNA (Z-HA) was inserted into the pUHD10-3 vector at the EcoRI site and the SspI site was replaced with the HindIII site by a HindIII linker. To construct a tetracycline (tet)-regulatable Z expression vector, tTA-dependent promoter flanked with HA-tagged chicken Z cDNA were recovered from pUHD10-3-Z-HA by digestion with HindIII and inserted into the HindIII site of ptTA2-Neo vector (Clontech) that encode tet-repressible tTA (tetR-VP16). The resulting plasmid (ptTA2-Neo-tetZ-HA) expresses Z-HA protein under the control of the tetR-VP16 (12).

Cell Culture and Transfection-- DT40 cells were cultured in RPMI1640 medium containing 10% (v/v) fetal bovine serum, 5% (v/v) chicken serum, 10 µM 2-mercaptoethanol, and antibiotics (penicillin and streptomycin) at 39.5 °C under 5% CO2. Cells were electroporated at 25 microfarads and 550 V (Bio-Rad) as described previously (13). Stable transformants were selected with each drug at the following concentrations: 2.0 mg/ml Geneticin (Sigma), 0.5 µg/ml puromycin (Sigma), 50 µg/ml blasticidin-S (Funakoshi), and 0.3 mg/ml phleomycin (Sigma). Cell viability was assayed by measuring the metabolic activity using tetrazolium salt WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt, Cell Counting Kit-8, Wako). After incubating the cells with WST-8, the optical density was read as specified by the manufacturer. Dox was used at a concentration of 2 µg/ml for the indicated times.

Antibodies-- Anti-chicken Z polyclonal antibody was raised in rabbits using a purified recombinant His-tagged Z protein expressed in Escherichia coli BL21. Anti-Hsp70 (MBL), anti-Hsp40 (Stress Gen), anti-actin (Chemicon), anti-Wee1 (Santa Cruz Biotechnology), anti-poly-ubiquitin (MBL), horseradish peroxidase-conjugated anti-rabbit and anti-mouse IgG antibodies (Amersham Biosciences) were purchased.

Western Blot Analysis-- Cells were lysed in 50 mM Tris-HCl (pH 8.0) containing 0.1% TritonX-100 and protease inhibitor mixture (Roche Molecular Biochemicals). Following a brief sonication, the extracts were cleared by centrifugation and subjected to 10-20% SDS-PAGE (14). After transfer onto polyvinylidene difluoride membranes (Millipore), proteins were detected by specific antibodies with the ECL method (Amersham Biosciences). Protein concentration was measured by the method of Bradford with bovine serum albumin as a standard (15).

Southern Blot Analysis-- Genomic DNAs were isolated by using a DNeasy tissue kit (Qiagen). Genomic DNA (15 µg) was digested with EcoRI, separated in a 0.7% (w/v) agarose gel, and transferred onto a Hybond N+ nylon membrane (Amersham Biosciences). The membrane was hybridized with 32P-labeled probe (ClaI-EcoRI fragment indicated in Fig. 1A), washed at high stringency, and then autoradiographed.

Northern Blot Analysis-- Total RNAs were isolated by using an RNeasy Mini kit (Qiagen). Approximately 15 µg of total RNAs was separated and transferred onto a Hybond N+ nylon membrane. The membrane was hybridized with 32P-labeled full-length chicken Z cDNA probe, washed at high stringency, and then autoradiographed.

Glycerol Gradient Fraction-- Cells were lysed in 25 mM Tris-HCl (pH 7.5) containing 1 mM dithiothreitol with 2 mM ATP by sonication, and the lysates were centrifuged at 15,000 × g for 30 min. The supernatants were subjected to glycerol gradient centrifugation with 10-40% glycerol in the above buffer. After centrifugation at 83,000 × g for 22 h using a Beckman SW28 rotor, the gradient was separated into 30 fractions of 1 ml each (16).

Assay of Peptidase Activity-- Hydrolysis of the synthetic peptides, succinyl-Leu-Leu-Val-Tyr-7-amino-4-methycoumarine (Suc-LLVY-AMC), t-butyloxycarbonyl-Leu-Arg-Arg-AMC (Boc-LRR-AMC), and carbobenzoxy-Leu-Leu-Glu-AMC (Z-LLE-AMC) was measured under the presence or absence of 0.05% SDS as described previously (17). One unit of peptidase activity was defined as the amount that degraded 1 nmol of a given fluorogenic peptide per minute.

Assay of [35S]ODC Degradation Activity-- 35S-Labeled ornithine decarboxylase (ODC) was produced in vitro by translating rat ODC mRNA in rabbit reticulocyte lysates with 35S-labeled Met and Cys (PerkinElmer Life Sciences) and then immunopurified. The degradation of ODC was assayed as described previously (17). In brief, 35S-labeled ODC (3000-4000 cpm) was incubated with antizyme, ATP, and enzyme solution in buffer containing the ATP regeneration system at 37 °C for 1 h. The reaction mixtures were then precipitated with trichloroacetic acid, the radioactivity of the trichloroacetic acid-soluble fraction was measured, and the activity was expressed as a percentage of total ODC radioactivity added.

Flow Cytometric Analysis-- Cells were fixed in 70% ethanol in phosphate-buffered saline at 4 °C. Fixed cells were washed in phosphate-buffered saline, incubated with 0.25 mg/ml RNase A at 37 °C, and stained with 10 µg/ml propidium iodide at 4 °C. DNA contents were measured by a flow cytometry and cell cycle profiles were analyzed by the Expo ADC analysis program (Beckman Coulter).

Immunofluorescence and TUNEL Assay-- Cells were fixed in 1% paraformaldehyde. For immunofluorescence analysis, anti-HA monoclonal antibody (BAbCO) and Alexa Fluor 594 goat anti-mouse IgG antibody (Molecular Probes) were used. Nuclei were counterstained with TOTO3 (Molecular Probes). Apoptotic cells were detected by TdT-mediated dUTP-biotin nick end-labeling (TUNEL) assay using an Apoptag kit (Intergen). The assay was performed according to instructions provided by the manufacturer. Fluorescence images were obtained using a confocal laser microscope (Zeiss and Bio-Rad).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Genetic Manipulation of Proteasome Function-- To examine the cellular roles of proteasomes in vertebrates, we generated a cell line that could genetically manipulate the level of the proteasome subunit that confers a peptidase activity. Chicken B cell line DT40 is advantageous for this purpose, because of its efficient rate of homologous recombination (13). Full-length chicken Z cDNA was obtained by screening a chicken muscle cDNA library using the partial cDNA fragment obtained by reverse transcription-PCR. The full-length chicken Z cDNA deduced a protein of 277 amino acids (accession number AB098728), displaying 57.4% and 83.8% identities with Saccharomyces cerevisiae and human, respectively, at the amino acid level. To disrupt the proteasome Z gene (cpsmb7), chicken Z genomic DNA was isolated from chicken genomic DNA library, and the targeting vectors were constructed as shown in Fig. 1A. The vectors were designed to create a null allele by replacing the DNA segment that encompasses exon 1 to exon 3, which encodes the first 85 amino acids, including the essential catalytic site (threonine 44 in the exon 2), with drug-resistant cassettes. DT40 cells that contain three functional Z genes (cpsmb7) were successively transfected with each targeting vector, and the homologously recombined clones were identified by genomic Southern blot (Fig. 1B). Because the null mutant was expected to be lethal, we transfected the tet-regulatable Z-HA expression vector (ptTA2-Neo-tetZ-HA vector), in which the expression of Z protein could be shut off by Dox treatment, and isolated their stable transformants after the first allele was disrupted by Bsd construct. The second and third loci were disrupted by Puro and Bleo constructs, respectively. Finally, we obtained the Z-/-/-/Z-HA clone that expressed Z-HA in a Z-nullizygous genetic background. The genomic Southern blots of representative clones are shown in Fig. 1B. Homologous recombination was identified as appearance of new 5.2-, 12-, and 11.5-kb bands corresponding to the targeted alleles generated by the Bsd, Puro, and Bleo constructs, respectively.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 1.   Conditional knockdown of proteasome Z subunit in DT40 cells. A, schematic representation of part of Z locus and targeting vectors. Wild-type (WT) and targeted alleles (Z/Bsd, Z/Puro, and Z/Bleo) are shown. B, genomic Southern blot analysis of wild-type (+/+/+), two heterozygous mutants (+/+/- and +/-/-), and homozygous mutant (-/-/-). Genomic DNAs were digested with EcoRI and hybridized with the probe indicated in A. C, expression of Z-HA mRNA upon Dox treatment. Z-/-/-/Z-HA cells were Dox-treated for the indicated times, and total RNAs were subjected to Northern blot analysis. Expression of Z-HA (top) and ethidium bromide staining of the total RNAs (bottom) are shown. D, expression of Z-HA protein upon Dox treatment. Cell extracts (2 µg of protein), obtained from cells treated as in C, were Western blotted with anti-chicken Z antibody. The lower signal is the mature form (solid arrowhead), whereas the upper signal corresponds to the precursor form (open arrowhead).

We then tested the effect of Dox treatment on Z-HA expression in Z-/-/-/Z-HA cells. Dox treatment of Z-/-/-/Z-HA cells reduced the mRNA and protein expression of Z-HA to undetectable levels at 24 h after Dox treatment (Fig. 1, C and D). Western blot with anti-Z antibody detected both precursor and mature forms of Z-HA. The latter form migrated below the size of the former (Fig. 1D). It is known that the catalytic subunits are synthesized as precursor forms and processed into the mature form during the assembly of the 20 S proteasome complex (18). The mature form co-sedimented with the 20 S proteasome, whereas the precursor form was detected in the lighter fraction when the cell extracts were fractionated by glycerol density gradient centrifugation (see Fig. 3, lower panels), suggesting that Z-HA is processed and incorporated into the 20 S proteasome.

Depletion of Z Subunit Resulted in Loss of Proteasome Activity-- Based on yeast studies, Pup1p, which corresponds to Z/beta 2, is known to confer trypsin-like activity (19, 20). In the next step, we tested whether loss of Z results in specific loss of trypsin-like activity. After Dox treatment, cells were serially collected at the indicated times and cell fractions were prepared. The cell fractions were first tested for their ability to degrade ODC, a proteasome-specific substrate independent of ubiquitination. As shown in Fig. 2A, ODC-degrading activities gradually decreased upon Dox treatment. These effects were not seen in Dox-untreated cells or Dox-treated wild-type DT40 cells. Testing for the specificity of peptidase activities showed that not only trypsin-like activity, but also other peptidase chymotrypsin-like and caspase-like activities were reduced (Fig. 2, B-D).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 2.   Proteasome activities in Dox-treated Z-/-/-/Z-HA cells. Cell extracts (20 µg of protein) were obtained from Dox-treated or untreated cells for indicated times, and peptidase activities were measured against ODC (A) and synthetic peptides; i.e. a chymotrypsin-like (B, Suc-LLVY-AMC), a trypsin-like (C, Boc-LRR-AMC), and a caspase-like (D, Z-LLE-AMC) activities. Open circles, Dox-untreated Z-/-/-/Z-HA cells; solid circles, Dox-treated Z-/-/-/Z-HA cells; open triangles, Dox-untreated wild-type cells; solid triangles, Dox-treated wild-type cells. Note that a caspase-like activity was assayed in the presence of 0.05% SDS, whereas the chymotrypsin-like and trypsin-like activities were without SDS (for the reason, see Fig. 3, upper panels, and text). Data represent the mean ± S.D. values of four independent analyses.

To further confirm that these peptidase activities represent proteasome-specific activities, Z-/-/-/Z-HA cells were treated with or without Dox for 30 h, and the cell extracts were further fractionated by glycerol density gradient centrifugation and subjected to peptidase assay and Western blot analysis. As shown in Fig. 3 (upper panels), in wild-type cells, active enzyme with chymotrypsin-like and trypsin-like activities was sedimented with a sedimentation coefficient of ~26 S, but low activity was found in slowly sedimenting fractions corresponding to the sedimentation position of the purified 20 S proteasome. Addition of 0.05% SDS, which is a potent artificial activator of the latent 20 S proteasome, caused marked enhancement of chymotrypsin-like activity in fractions sedimenting like the 20 S proteasome, as reported previously (16). Note that no obvious caspase-like activity was observed without SDS, but its strong activity could be measured in the presence of 0.05% SDS. ODC-degrading activity as well as these three types of peptidase activities were high and comparable in the Dox-untreated Z-/-/-/Z-HA cells at wild-type levels, whereas they were greatly decreased in the Dox-treated Z-/-/-/Z-HA cells (Fig. 3, upper panels).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 3.   Sedimentation velocity analysis of wild-type and Z-/-/-/Z-HA cell extracts. Samples (4 mg of protein) of the wild-type (WT) and Z-/-/-/Z-HA cells treated with or without Dox for 30 h were fractionated by glycerol density gradient centrifugation (10-40% glycerol from fractions 1 to 30) as described under "Experimental Procedures." After fractionation, aliquots (20 µl) of individual fractions were used for an assay of three peptide hydrolysis with (solid circles) or without (open circles) 0.05% SDS. The degradation of 35S-ODC (crosses) was also assayed. Elution positions of purified 20 and 26 S proteasomes are shown. Lower panel, Western blot analysis. Proteins in 200 µl of each fraction were precipitated with acetone, subjected to SDS-PAGE, and stained by Western blot analysis using an anti-chicken Z antibody. Numbers correspond to fraction numbers in the upper panels. The solid and open arrowheads point to the mature and precursor forms of Z, respectively, similar to Fig. 1D.

Western blot analysis revealed that the mature form of Z protein migrated in the fractions 11-19 with 20-26 S proteasomes (Fig. 3, lower panels). The precursor form of Z in wild-type cell extracts migrated at lighter fractions 7-11. These fractions corresponded to 16 S pre-proteasomal particles as reported previously (18). On the other hand, the precursor Z-HA in Dox-untreated Z-/-/-/Z-HA cell extracts was recovered in fractions 1-11. The precursor Z-HA observed in fractions 1-5 might be the free form based on its exogenous overexpression. Nonetheless, most mature Z-HA was recovered in the fractions containing sediments of 20-26 S proteasomes, indicating that Z-HA is assembled into these proteasomes. Of note, in the Z-/-/-/Z-HA cells with Dox, the mature Z-HA was reduced, and precursor Z-HA was not observed in fractions 7-11. In addition, very low mature Z-HA was recovered near top fractions 1-5, which might be generated by disassembly of the 20 S proteasome.

The peptidase activities in fractions of the mature form of Z-HA were high in untreated cells, whereas they were markedly low in Dox-treated cells fractionated in the same manner (Fig. 3, upper panels). Taken together, these results suggest that Z-HA is functionally active and that proteasome activity is dependent on the expression of Z-HA. Because not only trypsin-like activity but also other peptidase activities were affected by loss of Z-HA, we concluded that the integral functions of the proteasome are impaired probably due to its inappropriate assembly and/or maintenance of the complex.

Accumulation of Poly-ubiquitinated Proteins Associated with Loss of Z-- In the next experiment, we analyzed the levels of cellular poly-ubiquitinated proteins after Z depletion. After wild-type DT40 and Z-/-/-/Z-HA cells had been treated with Dox for 30 h, these cell extracts were analyzed by Western blotting using an anti-poly-ubiquitin antibody. As shown in Fig. 4, poly-ubiquitinated proteins considerably increased in crude extracts from the Z-/-/-/Z-HA cells by Dox treatment, whereas the pattern of poly-ubiquitinated proteins remained unchanged in wild-type cells, irrespective of Dox treatment. These results suggested that the dysfunction of proteasomes leads to accumulation of poly-ubiquitinated proteins.


View larger version (67K):
[in this window]
[in a new window]
 
Fig. 4.   Accumulation of poly-ubiquitinated proteins in Z-/-/-/Z-HA cells. The wild-type (WT) and Z-/-/-/Z-HA cells were treated with (+) or without (-) Dox for 30 h. Cell extracts (10 µg of protein) were subjected to Western blot analysis using an anti-poly-ubiquitin antibody.

Z Subunit Is Essential for Viability-- Because most of the proteasome subunit is essential in yeast, we tested the effect of loss of proteasome function on cell viability of Z-/-/-/Z-HA cells. For this purpose, Z-/-/-/Z-HA cells were treated with Dox for the indicated times and their viability was measured (Fig. 5A). Dox-treated Z-/-/-/Z-HA cells proliferated in the first 24 h but began to decrease from 30 h of treatment. Flow cytometric analysis of these cells showed their arrest at G2/M phase (Fig. 5B). We next examined the expression of Wee1 kinase, which plays a role in checkpoint mechanism at G2/M phase (21). Considerable accumulation of Wee1 kinase was noted at 24 h after Dox treatment (Fig. 5C). Furthermore, flow cytometry revealed cell death at 30 h after Dox treatment (Fig. 5B). To examine whether this was due to apoptosis, we performed TUNEL analysis (Fig. 5D). The apoptotic cells had large nuclei and less Z-HA expression. Taken together, these results indicated that loss of Z-HA and proteasomal activities result in cell-cycle arrest at G2/M phase followed by cell death. It is worth noting that residual Z-HA was present mainly in the cytoplasm as a punctate-like structure and to a lesser extent in the nuclei of Dox-treated cells, whereas it was uniformly present in the cytoplasm and rather abundantly in the nuclei of untreated cells (Fig. 5D).


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 5.   The Z subunit is essential for cell viability. A, cell survival after Dox treatment. Z-/-/-/Z-HA cells (2 × 104cells) were cultured in the presence (solid circles) or absence (open circles) of Dox for indicated times (0, 6, 24, 30, and 48 h), and their viabilities were measured. Data represent the mean ± S.D. values of four independent analyses. B, cell cycle analysis. Cells were treated as in A and subjected to flow cytometric analyses. Left panel, Dox-untreated Z-/-/-/Z-HA cells; right panel, Dox-treated Z-/-/-/Z-HA cells. Displayed data show typical patterns, and essentially similar results were obtained in at least three independent experiments. C, increment of Wee1 in Z-depleted cells. The crude extracts (20 µg of protein), prepared from wild-type (WT) (upper panels) and Z-/-/-/Z-HA (lower panels) cells that had been cultured with or without Dox for 24 h were immunoblotted with anti-Wee1 antibody. D, immunofluorescence analysis. Cells were treated as in A for the indicated times (0, 30, and 48 h) and mounted onto slides, fixed, and stained. DNA stain (TOTO-3, blue), the expression of Z-HA (alpha HA, red), and apoptotic signals (TUNEL, green), in the same cells are shown together with the merged images (Merge).

Enhanced Expression of Hsp70 and Hsp40 in Proteasome-defective Cells-- It is known that damaged proteins and/or misfolded proteins are rapidly eliminated from the cells by the ubiquitin-proteasome system. Indeed, proteasome inhibitors induce accumulation of such abnormal proteins in the cells and trigger signals that up-regulate the expression of certain molecular chaperones in the cells (22). Given that the expression of proteasomes can be reduced in Z-/-/-/Z-HA cells, we next examined whether Z depletion could up-regulate the expressions of major molecular chaperones, Hsp40 and Hsp70 in Z-/-/-/Z-HA cells. As shown in Fig. 6 (lower panels), Hsp40 and Hsp70 were consistently up-regulated by Z depletion in Z-/-/-/Z-HA cells. In contrast, these effects were not observed in Dox-treated wild-type DT40 cells (Fig. 6, upper panels). These results suggested that these molecular chaperones are up-regulated upon loss of proteasome function.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 6.   Enhanced expression of molecular chaperones Hsp70 and Hsp40 in Dox-treated Z-/-/-/Z-HA cells. Wild-type (WT) (upper panels) and Z-/-/-/Z-HA (lower panels) cells were treated with or without Dox for 30 h. Cell extracts (10 µg of protein) were prepared and used for immunoblotting with antibodies against Z, Hsp40, Hsp70, and actin. The solid arrowheads indicate the respective proteins, whereas open arrowheads show the precursor form of Z.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The proteasome is a multifunctional protease complex and essential for cell viability. We generated Z-/-/-/Z-HA cell line in which the expression of proteasome subunit Z could be manipulated by Dox. This cell line expressed Dox-repressible Z protein, tagged with C-terminal HA peptide. The C-terminal HA-tag did not interfere with the wild-type function of Z, because (i) Z-HA complemented the lethality of Z null-phenotype (Fig. 5A) and (ii) Z-HA was processed in mature form and incorporated into the proteasome complex (Figs. 1D and 3). Depletion of Z-HA resulted in inhibition of three types of proteasomal peptidase activities and ODC-degrading activity (Figs. 2 and 3). Furthermore, considerable accumulation of poly-ubiquitinated cellular proteins was observed in vivo (Fig. 4). This is consistent with the fact that cellular poly-ubiquitinated proteins accumulate in the yeast proteasomal temperature-sensitive mutants under restrictive temperature (23). Taken together, these results suggest that the Z subunit is essential for the integrity of proteasome.

The proteasome is the major protease for poly-ubiquitinated proteins and known to degrade many cell-cycle regulators during the cell cycle progression. Most of the yeast proteasome subunit mutants, although not all, exhibit cell-cycle arrest at the G2/M phase rather than the G1/S phase (24). Our data also indicate that the major function of the proteasome in cell-cycle regulation is required at the G2/M phase rather than the G1/S phase. The essential substrates to be degraded by the proteasome at G2/M phase were not characterized in this study; however, we observed accumulation of Wee1 kinase in Z-HA knockdown cells (Fig. 5C). The Wee1 kinase is known to phosphorylate cyclin-dependent kinase 1 and thus plays a critical role in the checkpoint mechanism by inhibiting cyclin-dependent kinase 1 activity (21). Whether Wee1 kinase is one of the essential substrates or simply accumulates due to cell-cycle arrest at G2/M phase remains to be elucidated.

The ubiquitin-proteasome system has been implicated in quality control of proteins in the cytosol and endoplasmic reticulum (ER). Accumulation of unfolded proteins in the ER induces the unfolded protein response (UPR), which (i) halts the translation of newly synthesized proteins, (ii) enhances the expression of molecular chaperones, and (iii) back translocates unfolded protein in the ER to the cytosol for proteasome degradation (25). The last process is called ER-associated protein degradation among the UPR reactions (26). In the present study, our results showed that inhibition of the proteasome enhances the expression of Hsp70 and Hsp40. The latter is known to collaborate with the former for folding newly synthesized and damaged proteins (27). How the cells sense the level of the proteasome and induce these molecular chaperones is unknown at present. However, this process is most likely due to enhanced UPR, because failure of protein degradation results in accumulation of abnormal proteins. Furthermore, the expression of molecular chaperone might be further enhanced following failure of the ER-associated protein degradation pathway.

Ubiquitin and proteasome-dependent protein degradation play essential roles in various biological events as mentioned in the introduction. In this regard, recent studies in the ubiquitin field reveal novel functions for ubiquitin in various biological events such as endocytosis, DNA repair, transcriptional regulation, and kinase activation (28). Whether these events do or do not involve proteasome-dependent degradation remain to be elucidated by genetic means, because proteasome inhibitors are known to inhibit some of the above biological events, such as endocytosis (29). Furthermore, many de-ubiquitinating enzymes that counteract with ubiquitination are vital in the cells (28). Thus, Z-/-/-/Z-HA cells could be used as a tool for examining the function of proteasomes in various cellular events that, at least, involve ubiquitination.

    ACKNOWLEDGEMENTS

We thank Y. Yamaguchi-Iwai for providing the parental DT40 cell line, the drug-resistance cassettes, and the pUHD10-3 vector and Y. Murakami for providing ODC and antizyme. We also thank K. Iwatsuki, T. Yasuda, and all members of the Tanaka laboratory for the advice and technical assistance.

    FOOTNOTES

* This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AB098728.

To whom correspondence should be addressed. Tel./Fax: 81-3-3823-2237; E-mail: tchiba@rinshoken.or.jp.

Published, JBC Papers in Press, February 19, 2003, DOI 10.1074/jbc.M301331200

    ABBREVIATIONS

The abbreviations used are: HA, hemagglutinin; Bleo, phleomycin; Boc-LRR-AMC, t-butyloxycarbonyl-Leu-Arg-Arg-AMC; Bsd, blasticidin; Dox, doxycycline; ODC, ornithine decarboxylase; Puro, puromycin; Suc-LLVY-AMC, succinyl-Leu-Leu-Val-Tyr-7-amino-4-methycoumarine; tTA, tetracycline-controlled transactivator; Z-LLE-AMC, carbobenzoxy-Leu-Leu-Glu-AMC; TdT, terminal deoxytransferase; WST-8, 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt; TUNEL, TdT-mediated dUTP-biotin nick end-labeling; ER, endoplasmic reticulum; UPR, unfolded protein response.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Coux, O., Tanaka, K., and Goldberg, A. L. (1996) Annu. Rev. Biochem. 65, 801-847[CrossRef][Medline] [Order article via Infotrieve]
2. Baumeister, W., Walz, J., Zuhl, F., and Seemuller, E. (1998) Cell 92, 367-380[Medline] [Order article via Infotrieve]
3. Groll, M., Ditzel, L., Lowe, J., Stock, D., Bochtler, M., Bartunik, H. D., and Huber, R. (1997) Nature 386, 463-471[CrossRef][Medline] [Order article via Infotrieve]
4. Unno, M., Mizushima, T., Morimoto, Y., Tomisugi, Y., Tanaka, K., Yasuoka, N., and Tsukihara, T. (2002) Structure 10, 609-618[CrossRef][Medline] [Order article via Infotrieve]
5. Hershko, A., and Ciechanover, A. (1998) Annu. Rev. Biochem. 67, 425-479[CrossRef][Medline] [Order article via Infotrieve]
6. Pickart, C. M. (2001) Annu. Rev. Biochem. 70, 503-533[CrossRef][Medline] [Order article via Infotrieve]
7. Hochstrasser, M. (1997) Annu. Rev. Genet. 30, 405-439
8. Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L. (1994) Cell 78, 761-771[Medline] [Order article via Infotrieve]
9. Bogyo, M., McMaster, J. S., Gaczynska, M., Tortorella, D., Goldberg, A. L., and Ploegh, H. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 6629-6634[Abstract/Free Full Text]
10. Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., and Schreiber, S. L. (1995) Science 268, 726-731[Medline] [Order article via Infotrieve]
11. Kim, K. B., Myung, J., Sin, N., and Crews, C. M. (1999) Bioorg. Med. Chem. Lett. 9, 3335-3340[CrossRef][Medline] [Order article via Infotrieve]
12. Gossen, M., and Bujard, H. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5547-5551[Abstract]
13. Buerstedde, J. M., and Takeda, S. (1991) Cell 67, 179-188[Medline] [Order article via Infotrieve]
14. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
15. Bradford, K. D. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
16. Tanahashi, N., Murakami, Y., Minami, Y., Shimbara, N., Hendil, K. B., and Tanaka, K. (2000) J. Biol. Chem. 275, 14336-14345[Abstract/Free Full Text]
17. Tanaka, K., Yoshimura, T., Kumatori, A., Ichihara, A., Ikai, A., Nishigai, M., Kameyama, K., and Takagi, T. (1988) J. Biol. Chem. 263, 16209-16217[Abstract/Free Full Text]
18. Schmidtke, G., Schmidt, M., and Kloetzel, P.-M. (1997) J. Mol. Biol. 268, 95-106[CrossRef][Medline] [Order article via Infotrieve]
19. Arendt, C. S., and Hochstrasser, M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 7156-7161[Abstract/Free Full Text]
20. Heinemeyer, W., Fischer, M., Krimmer, T., Stachon, U., and Wolf, D. H. (1997) J. Biol. Chem. 272, 25200-25209[Abstract/Free Full Text]
21. Russell, P., and Nurse, P. (1987) Cell 49, 559-567[Medline] [Order article via Infotrieve]
22. Sherman, M. Y., and Goldberg, A. L. (2001) Neuron 29, 15-32[Medline] [Order article via Infotrieve]
23. Kominami, K., DeMartino, G. N., Moomaw, C. R., Slaughter, C. A., Shimbara, N., Fujimuro, M., Yokosawa, H., Hisamatsu, H., Tanahashi, N., Shimizu, Y., Tanaka, K., and Toh-e, A. (1995) EMBO J. 14, 3105-3115[Abstract]
24. Ghislain, M., Udvardy, A., and Mann, C. (1993) Nature 366, 358-362[CrossRef][Medline] [Order article via Infotrieve]
25. Ma, Y., and Hendershot, L. M. (2001) Cell 107, 827-830[Medline] [Order article via Infotrieve]
26. Plemper, R. K., and Wolf, D. H. (1999) Trends Biochem. Sci 24, 266-270[CrossRef][Medline] [Order article via Infotrieve]
27. Frydman, J. (2001) Annu. Rev. Biochem. 70, 603-647[CrossRef][Medline] [Order article via Infotrieve]
28. Weissman, A. M. (2001) Nat. Rev. Mol. Cell Biol. 2, 169-178[CrossRef][Medline] [Order article via Infotrieve]
29. Longva, K. E., Blystad, F. D., Stang, E., Larsen, A. M., Johannessen, L. E., and Madshus, I. H. (2002) J. Cell Biol. 5, 843-854[CrossRef]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.